Calithera Biosciences Inc expected to post a loss of $1.93 a share - Earnings Preview

Calithera Biosciences

05/11/2022 03:11

* Calithera Biosciences Inc  CALA.OQ   CALA.O  is expected
to show
a fall in quarterly revenue when it reports  results on November
7 (estimated). 
    * The South San Francisco California-based  company is
expected to
report  a 85.2% decrease in revenue to $1 million from $6.75
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Calithera
Biosciences Inc
is for a loss of $1.93 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Calithera
Biosciences Inc is $17​, above​ its last closing price of $2.53.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -2.66       -2.65      -1.59     Beat    40.1
 Mar. 31 2022  -3.85       -3.70      -3.60     Beat    2.7
 Dec. 31 2021  -5.30       -4.80      -4.80     Met     0​
 Sep. 30 2021  -4.42       -4.56      -3.00     Beat    34.2
 ​​Jun.        -4.77       -4.81      -3.80     Beat    20.9
 30 2021                                                
 Mar. 31 2021  -5.37       -5.52      -5.60     Missed  -1.4​
 Dec. 31 2020  -6.60       -6.48      -6.40     Beat    1.2
 Sep. 30 2020  -6.26       -6.21      -6.40     Missed  -3.1
 This summary was machine generated November 5 at 03:11 GMT.  All
figures in US dollars  unless otherwise stated